Skip to Main Content

Paper Details

Reversible epigenetic alterations mediate PSMA expression heterogeneity in advanced metastatic prostate cancer.
JCI Insight
11
2023
FOLH1 gene, FOLH1 locus, H3K27, HDAC, MUC1, PSMA, PSMA-negative tumors, Prostate-specific membrane antigen, advanced metastatic prostate cancer, histone 3, histone deacetylase, lysine, mCRPC, metastatic castration-resistant prostate cancer, negative site, patient, prostate cancer
Author NameAffiliation
Ilsa ColemanFred Hutchinson Cancer Center
Jin-Yih LowFred Hutchinson Cancer Center
David A QuigleyUCSF Helen Diller Family Comprehensive Cancer Center
Lawrence D True
Felix Y FengUCSF Helen Diller Family Comprehensive Cancer Center
Eva CoreyUniversity of Washington (UW)
Colm MorrisseyUniversity of Washington (UW)
Peter S NelsonFred Hutchinson Cancer Center
Peter S Nelson
Peter S NelsonDivision of Clinical Research, Fred Hutchinson Cancer Center
Peter S Nelson
Peter S NelsonUniversity of Washington (UW)
Peter S NelsonFred Hutchinson Cancer Center
Peter S NelsonUniversity of Washington (UW)
Peter S Nelson
Peter S NelsonDivision of Clinical Research, Fred Hutchinson Cancer Center
Peter S Nelson
Michael C HaffnerFred Hutchinson Cancer Center
Michael C HaffnerDivision of Clinical Research, Fred Hutchinson Cancer Center
Michael C Haffner
  • 1 - 20

Datasets

Release 1.2